Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-11626.3Germany
BA.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BA.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
BA.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BA.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BA.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.2 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.2 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.2 (Alpha)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Q.2 (Alpha)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Q.2 (Alpha)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Q.2 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.2 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.2 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.66EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.66ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.66ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.66EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.66EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.66ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.66ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.485EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.485EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.485ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.485ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.485EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.485EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.485ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.485ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used